Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction - 42 CFR Part 8

ICR 201303-0930-002

OMB: 0930-0206

Federal Form Document

Forms and Documents
Document
Name
Status
Form and Instruction
Modified
Form and Instruction
Modified
Supporting Statement A
2013-05-23
IC Document Collections
ICR Details
0930-0206 201303-0930-002
Historical Active 201001-0930-001
HHS/SAMHSA 19136
Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction - 42 CFR Part 8
Revision of a currently approved collection   No
Regular
Approved with change 06/28/2013
Retrieve Notice of Action (NOA) 03/29/2013
  Inventory as of this Action Requested Previously Approved
06/30/2016 36 Months From Approved 06/30/2013
26,001 0 31,982
2,263 0 2,718
0 0 450,000

These regulations specify requirements for opioid treatment programs, which must apply for certification and adhere to recordkeeping, disclosure and reporting specifications. In addition, entities that wish to become accreditation bodies under the regulations must apply to and obtain approval from SAMHSA. Such bodies must develop and submit accreditation elements for SAMHSA acceptance. Upon designation as an accreditation body, entities must keep certain records of accreditation surveys and submit them to SAMHSA.

US Code: 42 USC 501 Name of Law: SAMHSA
  
None

Not associated with rulemaking

  78 FR 3013 01/15/2013
78 FR 16516 03/15/2013
No

2
IC Title Form No. Form Name
Reporting - Opioid Treatment Programs SMA-162, SMA-168 SMA-168 ,   SMA-162
Reporting - Accreditation Bodies SMA-163 SMA-163

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 26,001 31,982 0 -5,981 0 0
Annual Time Burden (Hours) 2,263 2,718 0 -455 0 0
Annual Cost Burden (Dollars) 0 450,000 0 0 -450,000 0
No
Yes
Miscellaneous Actions
Currently there are 2,718 total approved burden hours. The program is requesting 2,263.15. The decrease of 454 hours is due to the improvements and enhancements to the web-based online reporting system for forms SMA-162 and SMA-168. The forms available online include a unique online feature for both the SMA-162 and SMA-168 that pre-populates certain information within the form. This in turn reduces the program's time spent filling out the forms as well as the staff time spent on processing it. Importantly, this modest increase in the number of regulated entities responding has been offset by the online function. Also with the approval of the new regulation on buprenorphine there have been fewer patient exceptions necessary therefore reducing burden hours. The response number and total hours requested for accreditation organizations has increased slightly. This is due to the emphasis on patient (and other) complaint monitoring and accreditation organization follows up. The estimated burden in the tables accompanying this submission has been adjusted accordingly and indicates a decrease in the estimated information collection burden since the last submission. The net result of these re-estimations is an adjustment decrease of 454 hours from the previously approved level of 2,718 hours.

$450,000
No
No
No
No
No
Uncollected
Summer King 2402761243

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
03/29/2013


© 2024 OMB.report | Privacy Policy